Fidelis Capital Partners, LLC Boston Scientific Corp Transaction History
Fidelis Capital Partners, LLC
- $941 Billion
- Q1 2025
A detailed history of Fidelis Capital Partners, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 16,529 shares of BSX stock, worth $1.76 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
16,529
Previous 16,530
0.01%
Holding current value
$1.76 Million
Previous $1.7 Billion
1.14%
% of portfolio
0.18%
Previous 0.17%
Shares
10 transactions
Others Institutions Holding BSX
# of Institutions
1,829Shares Held
1.21BCall Options Held
9.66MPut Options Held
6.98M-
Vanguard Group Inc Valley Forge, PA135MShares$14.3 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$13.5 Billion0.22% of portfolio
-
State Street Corp Boston, MA64.5MShares$6.87 Billion0.28% of portfolio
-
Primecap Management CO Pasadena, CA36.5MShares$3.89 Billion3.11% of portfolio
-
Wellington Management Group LLP Boston, MA33.2MShares$3.54 Billion0.67% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $153B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...